BCAT2
BCAT2 (branched chain amino acid transaminase 2, also known as BCATm, BCAM and BCT2) is a mitochondrial aminotransferase that catalyses the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine and valine. It is a pyridoxal-phosphate-dependent enzyme. Browse Assay Genie's current range of BCAT2 research reagents below, or read on for the biology behind the target.
BCAT2 catalyses the first step in the breakdown of the essential branched chain amino acids leucine, isoleucine and valine. Beyond this core metabolic role, UniProt notes that branched chain amino acid catabolism contributes to adipocyte differentiation by supplying lipogenic acetyl-CoA pools in differentiated adipocytes. Mechanistically, acetyl-CoA derived from this catabolism is used by EP300/p300 to acetylate and inhibit PRDM16, which prevents adipose tissue browning. BCAT2 may also function as a transporter of branched chain alpha-keto acids.
The BCAT2 gene encodes a branched chain aminotransferase found in mitochondria, and the encoded protein forms a dimer. It belongs to the class-IV pyridoxal-phosphate-dependent aminotransferase family and carries the EC number 2.6.1.42. HGNC places the gene in the branched chain amino acid transaminase family, and also lists it within the minor histocompatibility antigens group. Multiple transcript variants encoding different isoforms have been reported for this gene, which is worth bearing in mind when choosing detection strategies for the BCAT2 protein.
The protein appears in the literature under several names: BCATm, BCAM and BCT2, as well as the previous gene name branched chain aminotransferase 2, mitochondrial. The "m" in BCATm refers to its mitochondrial location, which distinguishes it from the related cytosolic enzyme BCAT1. Mouse and rat both have a Bcat2 ortholog, so the BCAT2 gene can be studied in common rodent models of amino acid metabolism and adipose biology.
BCAT2 catalyses the first reaction in leucine, isoleucine and valine catabolism, making it a central enzyme for studying branched chain amino acid handling.
Branched chain amino acid catabolism provides lipogenic acetyl-CoA pools in differentiated adipocytes, linking BCAT2 activity to adipocyte differentiation.
Acetyl-CoA from this pathway is used by EP300/p300 to acetylate and inhibit PRDM16, preventing adipose tissue browning.
BCAT2 is a dimeric, pyridoxal-phosphate-dependent mitochondrial aminotransferase that may also act as a branched chain alpha-keto acid transporter.
BCAT2 catalyses the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine and valine. The resulting catabolism supplies acetyl-CoA pools that support lipogenesis in differentiated adipocytes, and BCAT2 may also function as a transporter of branched chain alpha-keto acids.
BCAT2 is also called BCATm, BCAM and BCT2, and was previously named branched chain aminotransferase 2, mitochondrial. UniProt lists the protein as branched-chain-amino-acid aminotransferase, mitochondrial. Multiple transcript variants encoding different isoforms have been described for the gene.
Mouse and rat both have a Bcat2 ortholog, so the enzyme can be studied in rodent models; check the datasheet of any product for its validated reactivity. BCAT2 is the mitochondrial branched chain aminotransferase, and it belongs to the same HGNC family as BCAT1.
Other branched chain aminotransferases, amino acid catabolism enzymes and adipocyte regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O15382; product specifications from Assay Genie datasheets.